Prevention of disorders of blood coagulation at the patients after total hysterectomy

Tarabrin, O.; Mazurenko, A.; Tarabrin, P.; Sazhyn, D.; Volodychev, D.

dc.contributor.author	Tarabrin, O.
dc.contributor.author	Mazurenko, A.
dc.contributor.author	Tarabrin, P.
dc.contributor.author	Sazhyn, D.
dc.contributor.author	Volodychev, D.
dc.date.accessioned	2020-06-15T09:11:54Z
dc.date.available	2020-06-15T09:11:54Z
dc.date.issued	2017
dc.identifier.citation	Prevention of disorders of blood coagulation at the patients after total hysterectomy / O. Tarabrin, A. Mazurenko., P. Tarabrin et al. // European Society of Anaesthesiology. 2017. Vol. 34. Abstract 12AP05-5.	uk_UA
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7341
dc.description.abstract	Acquired factor V deficiency (AFVD) is a rare but challenging bleeding disorder with approximately 150 cases reported in the literature. Its clinical presentation may span from the asymptomatic laboratory abnormalities to the life-threatening bleeding. Current recommendations emphasize the importance of decreasing the anti-FV antibody titre only if bleeding symptoms are present. (1) Based on this report, a new proposal for the treatment of asymptomatic AFVD patients could be made.	uk_UA
dc.language.iso	en	uk_UA
dc.subject	Prevention of the haemorrhage	uk_UA
dc.subject	bleeding	uk_UA
dc.title	Prevention of disorders of blood coagulation at the patients after total hysterectomy	uk_UA
dc.type	Article	uk_UA